ARA. I. Rathnayake

A. I. Rathnayake

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. I. Rathnayake has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Microalgae toxins in food products and impact on human health: a review

    by W. A. T. N. Withana, D. M. D. I. Gunarathna, D. M. G. I. Dissanayake, A. I. Rathnayake, H. K. S. de Zoysa, Viduranga Y. Waisundara

    Microalgal toxins are secondary metabolites synthesized by cyanobacteria, dinoflagellates, and diatoms in response to environmental stress. Humans and animals can be exposed to these toxic compounds through food, water, and aerosolized toxins and these toxic compounds are capable of causing acute and chronic health issues like paralysis, liver damage, cancer, and even death by employing several molecular mechanisms such as sodium channel blocking, protein phosphatase inhibition, cellular membrane disruption etc. Microalgal toxin poisoning through food products is a major concern as microalgae are largely consumed as dietary supplements. These toxins can easily bioaccumulate and be biomagnified via food chains. Hence, proper screening and quality control measures for these microalgal toxins should be implemented. Cytotoxins, dermatoxins, neurotoxins, hepatotoxins, and endotoxins are the main toxins produced by the microalgae. Microalgae are effectively incorporated into the food industry in a diverse range. Toxic contaminants from the microalgae are a silent threat to food security and human health. There are some regulatory models when consuming microalgae-related food products and water due to their toxic effects. Detecting the toxins in the initial stage, studying the impact of toxin production due to environmental factors, and developing effective mitigation strategies to ensure food safety, is a future needs in this field.


  • Open Access

    In Silico Study of 5,7-Dimethoxycoumarin and p-Coumaric Acid in Carica papaya Leaves as Dengue Virus Type 2 Protease Inhibitors

    by Samith Rathnayake, Ayesh Madushanka, N.D. Asha Dilrukshi Wijegunawardana, Harthika Mylvaganam, Ajith Rathnayake, Eranga Geethanjana Perera, Ishara Jayamanna, Priyantha Chandrasena, Ahinsa Ranaweera, Prasad Jayasooriya, et al.

    Dengue virus is a serious public health issue in tropical and subtropical regions. The global incidence of dengue necessitates the potent antiviral medication for the prevention of proliferation of the virus inside the human body. The DEN2 NS2B/NS3 protease, present in the dengue virus, is an attractive drug target due to its essential role in viral replication, survival, and other cellular activities. In traditional medicine, Carica papaya leaves have been used for the treatment of dengue fever in Sri Lanka, Pakistan, and Malaysia. Therefore, phytochemicals present in Carica papaya leaves have a potential anti-viral activity, and could be used as strong drug candidates against the dengue virus. In this investigation, two phytochemical compounds in Carica papaya leaves, 5,7-dimethoxycoumarin and p-coumaric acid, were selected from the literature and then docked against the DEN2 NS2B/NS3 protease. The compounds showed strong interactions with favorable binding energies in the active site of DEN2 NS2B/NS3 protease. To validate the molecular docking results, the docked ligand–protein complexes were subjected to molecular dynamic simulation along with the apo form of the protein for 30 ns. The molecular dynamic simulation analysis comprising root mean square deviation and fluctuation, the radius of gyration, hydrogen bonding, the Dictionary of Secondary Structure of Proteins (DSSP), and MM/PBSA, revealed the stability of the apo and complex systems. Interactions formed by these compounds with residues Leu149 and Asn152 were found to be essential for the stability of the ligand–protein complex. The findings revealed that these phytochemical compounds depict the promising results against the DEN2 serotype of the dengue virus and the potential for therapeutic drugs. Further experimentation on the proposed compounds is necessary to validate the results and could lead to the development of strong inhibitors with improved activity.